7-102439005-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001126340.3(ORAI2):c.49C>T(p.Pro17Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000874 in 1,614,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001126340.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ORAI2 | NM_001126340.3 | c.49C>T | p.Pro17Ser | missense_variant | 3/4 | ENST00000495936.7 | NP_001119812.1 | |
ORAI2 | NM_001271818.2 | c.49C>T | p.Pro17Ser | missense_variant | 3/4 | NP_001258747.1 | ||
ORAI2 | NM_032831.4 | c.49C>T | p.Pro17Ser | missense_variant | 2/3 | NP_116220.1 | ||
ORAI2 | NM_001271819.2 | c.-7+2672C>T | intron_variant | NP_001258748.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ORAI2 | ENST00000495936.7 | c.49C>T | p.Pro17Ser | missense_variant | 3/4 | 2 | NM_001126340.3 | ENSP00000420178 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000486 AC: 74AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251140Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135862
GnomAD4 exome AF: 0.0000458 AC: 67AN: 1461754Hom.: 0 Cov.: 31 AF XY: 0.0000440 AC XY: 32AN XY: 727176
GnomAD4 genome AF: 0.000486 AC: 74AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at